Vladimir Gilca
Vladimir Gilca
Institut national de santé publique
Verified email at inspq.qc.ca
Cited by
Cited by
Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
C Sauvageau, B Duval, V Gilca, F Lavoie, M Ouakki
BMC Public Health 7 (1), 1-6, 2007
Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs
B Duval, V Gilca, S McNeil, S Dobson, D Money, IM Gemmill, ...
Vaccine 25 (45), 7841-7847, 2007
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)
DM Skowronski, NZ Janjua, G De Serres, D Purych, V Gilca, ...
The Journal of infectious diseases 206 (12), 1852-1861, 2012
Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions
B Duval, V Gilca, N Boulianne, K Pielak, B Halperin, MA Simpson, ...
Journal of advanced nursing 65 (3), 499-508, 2009
Cost-effectiveness analyses of hepatitis a vaccine
AM Anonychuk, AC Tricco, CT Bauch, V Gilca, B Duval, A John-Baptiste, ...
Pharmacoeconomics 26 (1), 17-32, 2008
Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
B Duval, V Gîlca, N Boulianne, P De Wals, R Massé, G Trudeau, ...
The Pediatric infectious disease journal 24 (3), 213-218, 2005
Cost-utility of universal hepatitis A vaccination in Canada
CT Bauch, AM Anonychuk, BZ Pham, V Gilca, B Duval, MD Krahn
Vaccine 25 (51), 8536-8548, 2007
Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results
A Krawczyk, B Knäuper, V Gilca, E Dubé, S Perez, K Joyal-Desmarais, ...
Human vaccines & immunotherapeutics 11 (2), 322-329, 2015
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
V Gilca, G De Serres, N Boulianne, D Murphy, P De Wals, M Ouakki, ...
Vaccine 31 (3), 448-451, 2013
Determinants of parents’ decision to vaccinate their children against rotavirus: results of a longitudinal study
E Dubé, JA Bettinger, B Halperin, R Bradet, F Lavoie, C Sauvageau, ...
Health education research 27 (6), 1069-1080, 2012
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review
B Duval, G De Serres, V Gilca, AC Tricco, J Ochnio, DW Scheifele
BMC Infectious diseases 5 (1), 1-11, 2005
Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada
P De Wals, G Deceuninck, B Lefebvre, R Tsang, D Law, G De Serres, ...
Clinical Infectious Diseases 64 (9), 1263-1267, 2017
Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis
AC Tricco, CH Ng, V Gilca, A Anonychuk, S Berliner
BMC infectious diseases 11 (1), 1-15, 2011
Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
V Gilca, G De Serres, ME Hamelin, G Boivin, M Ouakki, N Boulianne, ...
Vaccine 30 (1), 35-41, 2011
Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A (H1N1) pandemic vaccine
E Dubé, V Gilca, C Sauvageau, N Boulianne, FD Boucher, JA Bettinger, ...
BMC Research Notes 3 (1), 1-5, 2010
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: methodological challenges and initial results of a pan-Canadian longitudinal …
S Perez, O Tatar, GK Shapiro, E Dubé, G Ogilvie, J Guichon, V Gilca, ...
BMC Public Health 16 (1), 1-17, 2016
Cross-reactive antibody to swine influenza A (H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in …
DM Skowronski, G De Serres, NZ Janjua, JL Gardy, V Gilca, M Dionne, ...
Eurosurveillance 17 (4), 20066, 2012
Burden of acute otitis media on Canadian families
E Dubé, P De Wals, V Gilca, N Boulianne, M Ouakki, F Lavoie, R Bradet
Canadian Family Physician 57 (1), 60-65, 2011
Nationwide Canadian study of hepatitis A antibody prevalence among children eight to thirteen years old
B Duval, G De Serres, J Ochnio, D Scheifele, V Gilca
The Pediatric infectious disease journal 24 (6), 514-519, 2005
A dynamic model for assessing universal Hepatitis A vaccination in Canada
CT Bauch, ASRS Rao, BZ Pham, M Krahn, V Gilca, B Duval, MH Chen, ...
Vaccine 25 (10), 1719-1726, 2007
The system can't perform the operation now. Try again later.
Articles 1–20